Suchergebnisse - "Martits-Chalangari, Katalin"

PubPharm (17)

1

Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis

enthalten in: Dermatologic therapy | 2022

von Mansouri, P. | Mozafari, N. | Chalangari, R. | +1

2

ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient : Case report

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2022

von Martits-Chalangari, K. | Spak, C. | Askar, M. | +8

3

Distal Versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention : Design and Rationale of the DIPRA Trial

enthalten in: Cardiovascular revascularization medicine : including molecular interventions | 2022

von Al-Azizi, K. | Idris, A. | Christensen, J. | +19

4

The Immunogenetics of Lichen Planus

enthalten in: Advances in experimental medicine and biology | 2022

von Mansouri, P. | Nikkhah, N. | Esmaeili, B. | +3

5

ALVR109, an off‐the‐shelf partially HLA matched SARS‐CoV‐2–specific T cell therapy, to treat refractory severe COVID‐19 pneumonia in a heart transplant patient : Case report

enthalten in: American Journal of Transplantation | 2022

von Martits‐Chalangari, K. | Spak, C. | Askar, M. | +8

6

Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis

enthalten in: Dermatologic Therapy | 2022

von Mansouri, P. | Mozafari, N. | Chalangari, R. | +1

7

De novo tacrolimus extended-release tablets (LCPT) versus twice-daily tacrolimus in adult heart transplantation : Results of a single-center non-inferiority matched control trial

enthalten in: Clinical transplantation | 2021

von van Zyl, J. | Sam, T. | Clark, D. | +11

8

Stevens-Johnson Syndrome due to COVID-19 vaccination

enthalten in: Clinical case reports | 2021

von Mansouri, P. | Chalangari, R. | Martits-Chalangari, K. | +1

9

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

enthalten in: The New England journal of medicine | 2021

von Dougan, M. | Nirula, A. | Azizad, M. | +131

10

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2021

von Chen, P. | Nirula, A. | Heller, B. | +120

CommentIn: N Engl J Med. 2020 Dec 30;384(2):. - PMID 33378610